Indianz.Com > COVID-19 > Indian Health Service (Department of Health and Human Services)
https://wp.me/pbXgss-4kv
Posted: January 11, 2022
ihscovid19vaccine

Image: Indian Health Service

The Indian Health Service has updated its coronavirus data, showing COVID-19 vaccination distribution and administration as of January 10, 2022.

According to the data, the IHS has distributed 2,603,525 COVID-19 vaccine doses across 11 areas of Indian Country. Of that amount, 2,051,040 have been administered, representing nearly 78.8 percent of the total.

The number of vaccines distributed by the IHS increased by 1.0 percent, according to a comparison of data from January 3. Meanwhile, the number of vaccines administered grew by almost 1.3 percent when compared to the week prior.

The Oklahoma City Area, where COVID-19 cases increased considerably following the availability of the vaccine in the spring of 2020, continues to account for the most vaccines received (629,660) and administered (492,905). The Navajo Area, where the pandemic has exacted a disproportionate toll since the spring of 2020, comes in second (386,565 distributed, 352,036 administered) while the California Area comes in third (306,245 distributed, 205,062 administered).

In all three areas, the number of doses administered, as well as the number of doses distributed, increased from the week prior. The three regions account for the largest number of IHS users, with the Phoenix Area also accounting for a large number (284,530 distributed, 233,472 administered). The Phoenix Area has been disproportionately affected by COVID-19 as well.

According to the IHS, vaccination distribution and administration will be updated weekly across the 11 areas that are receiving doses directly from the agency. However, data does not appear to have been released in the week immediately preceding the Christmas holiday.

Tribal health facilities in Alaska have chosen to receive their COVID-19 vaccine supplies from the state, so their region is not included in the data.

COVID-19 Vaccine Distribution and Administration by IHS Area

As of January 10, 2022, the IHS is distributing all three COVID-19 vaccines currently authorized or approved in the U.S, including Pfizer-BioNTech, Moderna, and Janssen/Johnson & Johnson. The table below shows the total number of vaccine doses distributed and administered to date, per IHS Area, for facilities that chose to receive vaccine through the IHS jurisdiction. The data includes COVID-19 vaccinations administered to all ages and specialty groups authorized for emergency use or fully licensed by the Food and Drug Administration (FDA). The IHS administration rate is 79 percent. The IHS jurisdiction is administering all available full doses in accordance with FDA guidance.

Area Total Doses Distributed* Total Doses Administered**
Albuquerque 174,075 173,348
Bemidji 212,835 164,478
Billings 111,325 71,962
California 306,245 205,062
Great Plains 205,530 142,628
Nashville 139,475 101,134
Navajo 386,565 352,036
Oklahoma City 629,660 492,905
Phoenix 284,530 233,472
Portland 137,795 102,392
Tucson 15,490 11,623
Grand Total 2,603,525 2,051,040

*Distributed Data Source: IHS National Supply Service Center, includes total doses ordered and delivered by January 7, 2021, to facilities that chose the IHS jurisdiction for vaccine distribution.

**Administered Data Source: Data is reported from the Vaccine Administration Management System (VAMS) and IHS Central Aggregator Service (CAS). Data may be different than data on the CDC COVID-19 Vaccine Tracker due to lags and ongoing quality review of data, including resolving data errors.

Note:The COVID-19 Vaccine Distribution and Administration by IHS Area data is only reflective of facilities that chose the IHS jurisdiction for vaccine distribution. Alaska Area data is not reported as all tribes chose to receive COVID-19 vaccine from the State of Alaska. The Tucson Area data only includes one tribe that chose the IHS jurisdiction for vaccine distribution.

Source: Indian Health Service (https://www.ihs.gov/coronavirus)

Join the Conversation